The FDA has cleared the start of clinical trial testing of KT-621, an experimental oral medication for COPD and other ...

Columnist Caroline Gainer is concerned about a couple of results from her recent annual wellness visit that could suggest ...

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

Many of us with chronic obstructive pulmonary disease (COPD) have received medical devices to help with our breathing. At first, it seemed to me that some of these devices worked better than others.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that causes several symptoms which make breathing difficult. These include persistent cough with mucus, wheezing, and shortness ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with poorly controlled chronic obstructive pulmonary disease (COPD) and high ...

Caroline Gainer is from West Virginia, the state with the highest rate of COPD in the United States. She was diagnosed with moderate-to-severe COPD in 2013 after a pneumothorax (lung collapse). After ...

The voice of people with chronic obstructive pulmonary disease (COPD) becomes more pitched and sounds breathy or hoarse at the early stages of disease exacerbations, which are episodes when symptoms ...